Indexation of left ventricular mass to body surface area and height to allometric power of 2.7: Is the difference limited to obese hypertensives?

Journal of Human Hypertension

Volumn 23, Issue 11, 2009, Pages 728-734

  Cuspidi, C ^a,b   Meani, S ^c   Negri, F ^a,b   Giudici, V ^b   Valerio, C ^b   Sala, C ^d   Zanchetti, A ^b,d   Mancia, G ^a,b,d  

^a UNIVERSITY OF MILANO BICOCCA   (Italy)

^b ISTITUTO AUXOLOGICO ITALIANO   (Italy)

^c RHO HOSPITAL   (Italy)

^d UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; CALCIUM ANTAGONIST; DIURETIC AGENT; INSULIN; ORAL ANTIDIABETIC AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY HEIGHT; BODY SURFACE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DIABETES MELLITUS; ECHOGRAPHY; FEMALE; GENDER BIAS; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; OBESITY; PREVALENCE; SEX RATIO;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BLOOD PRESSURE; BLOOD PRESSURE DETERMINATION; BODY HEIGHT; BODY SURFACE AREA; ECHOCARDIOGRAPHY, DOPPLER, PULSED; FEMALE; HEART VENTRICLES; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; MALE; MIDDLE AGED; MODELS, CARDIOVASCULAR; OBESITY; PREDICTIVE VALUE OF TESTS; PREVALENCE; REGISTRIES; SENSITIVITY AND SPECIFICITY; SPHYGMOMANOMETERS; YOUNG ADULT;

EID: 70350339632     PISSN: 09509240     EISSN: 14765527     Source Type: Journal    
DOI: 10.1038/jhh.2009.16     Document Type: Article

References (31)

1. Vakili BA, Okin PM, Devereux RB. Prognostic implications of left ventricular hypertrophy. Am Heart J 2001; 141: 334-341.
2. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli W. Prognostic implications of echocardiographicallydetermined left ventricular mass in the Framingham Study. N Engl J Med 1990; 322: 1561-1566.
3. Koren MJ, Devereux RB, Casale PN, Savage DD, Laragh JH. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Med Intern 1991; 114 345-352.
4. Liao Y, Cooper RS, McGee DL, Mensah GA, Ghali JK. The relative effects of left ventricular hypertrophy, coronary artery disease, and ventricular dysfunction on survival among black adults. JAMA 1995; 273: 1592-1597.
5. Kaplan N, Mendis S, Poulter N, Whitworth J, World Health Organization, International Society of Hypertension Writing Group. 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement of hypertension. World Health Organization, International Society of Hypertension Writing Group. J Hypertens 2003; 21: 1983-1992.
6. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo Jr JL, et al., National High Blood Pressure Education Program Coordinating Committee. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. The JNC 7 report. JAMA 2003; 289: 2560-2572.
7. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G et al. 2007 Guidelines for the Management of Arterial Hypertension. The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007; 25: 1105-1187.
8. Doll S, Paccaud F, Bovet P, Burnier M, Wietlisbach V. Body mass index, abdominal adiposity and blood pressure consistency of their association across developing and developed countries. Int J Obes Relat Metab Disord 2002; 26: 48-57.
9. Lauer MS, Anderson KM, Levy D. Separate and joint influences of obesity and mild hypertension on left ventricular mass and geometry: The Framingham Heart Study. J Am Coll Cardiol 1992; 19: 130-134.
10. de Simone G. State of the art in the metabolic syndrome. Nutr Metab Cardiovasc Dis 2005; 15: 239-241.
11. Corry DB, Tuck AM. Obesity, hypertension and sympathetic nervous system activity. Curr Hypertens Rep 1998; 1: 119-126.
12. Levy D, Labib SB, Anderson KM, Christiansen JC, Kannel WB, Castelli WP. Determinants of sensitivity and specificity of electrocardiographic criteria for left ventricular hypertrophy. Circulation 1990; 81 815-820.
13. de Simone G, Kizer JR, Chinali M, Roman MJ, Bella JN, Best LG, et al. for the Strong Heart Study Investigators. Normalization for body size and population attributable risk of left ventricular hypertrophy. Am J Hypertens 2005; 18: 191-196.
14. Chalmers A, Mac-Mahon S, Mancia G, Whitworth J, Beilin L, Hansson L et al. 1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension. Guidelines Subcommittee. J Hypertens 1999; 17: 151-183.
15. Zanchetti A, Cifkova R, Fagard R, Kjeldsen S, Mancia G, Poulter N et al. European Society of Hypertension-European Society of Cardiology Guidelines Committee. 2003 European Society of Hypertension/European Society of Cardiology guidelines for the management of arterial hypertension. Guidelines Committee. J Hypertens 2003; 21: 1011-1053.
16. Pi-Sunyer FX. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults - the evidence report. National Institutes of Health. Obes Res 1998; 6(Suppl 2): 51S-209S.
17. Cuspidi C, Meani S, Fusi V, Valerio C, Catini E, Sala C et al. Prevalence and correlates of left atrial enlargement in essential hypertension: Role of ventricular geometry and the metabolic syndrome. The Evaluation of Target Organ Damage in Hypertension study. J Hypertens 2005; 23: 875-882.
18. Devereux RB, Reichek N. Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation 1977; 55: 613-618.
19. de Simone G, Devereux RB, Daniels SR, Koren MJ, Meyer RA, Laragh JH. Effect of growth on variability of left ventricular mass; assessment of allometric signals in adults and children and their capacity to predict cardiovascular risk. J Am Coll Cardiol 1995; 25: 1056-1062.
20. Ganau A, Devereux RB, Roman MJ, de Simone G, Pickering TG, Saba PS et al. Patterns of left ventricular geometry and geometric remodelling in essential hypertension. J Am Coll Cardiol 1992; 19: 1550-1558.
21. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA et al. Diagnosis and management of the metabolic syndrome. An American Heart Association/National Heart, Lung and Blood Institute Scientific Statement. Circulation 2005; 112: 1-18.
22. Dewey FE, Rosenthal D, Murphy DJ, Froelicher VF, Ashley EA. Does size matter ? Clinical applications of scaling cardiac size and function for body size. Circulation 2008; 117: 2279-2287.
23. Coca A, Gabriel R, de la Figuera M, Lopez-Sendon JL, Fernandez R, Sagastagoistia JH, et al., on behalf of the VITAE Investigators. The impact of different echocardiographic diagnostic criteria on the prevalence of left ventricular hypertrophy in essential hypertension: the VITAE study. J Hypertens 1999; 17: 1471-1480.
24. Ferrara LA, Vaccaro O, Cardoni O, Laurenzi M, Mancini M, Zanchetti A. Indexation criteria of ventricular mass and predictive role of blood pressure and body composition. Am J Hypertens 2005; 18: 1282-1287.
25. Watchell K, Bella JN, Liebson PR, Gerdts E, Dahlof B, Aalto T et al. Impact of different partition values on prevalence of left ventricular hypertrophy and concentric geometry in a large hypertensive population. The LIFE study. Hypertension 2000; 35: 6-12.
26. Liao Y, Cooper RS, Durazu-Arzivu R, Mensah GA, Ghali JK. Prediction of mortality risk by different methods of indexation for left ventricular mass. J Am Coll Cardiol 1997; 58: 1072-1083.
27. Bella JN, Devereux RB, Roman MJ, O'Grady MJ, Welty TK, Lee ET, et al. for the Strong Heart Study Investigators. Relations of left ventricular mass to fatfree and adipose body mass: The Strong Heart Study. Circulation 1998; 98: 2538-2544.
28. De Simone G, Devereux RB, Maggioni AP, Gorini M, de Divitiis O, Verdecchia P. MAVI (Massa Ventricolare sinistra nell'Ipertensione) Study Group. Am J Hypertens 2005; 18: 1288-1293.
29. Cuspidi C, Esposito A, Negri F, Sala C, Masaidi M, Giudici V et al. Studies on left ventricular hypertrophy regression in arterial hypertension: A clear message for the clinician? Am J Hypertens 2008; 21: 458-463.
30. Cuspidi C, Valerio C, Sala C, Muiesan ML, Grandi AM, Palumbo G et al. on behalf of the Lombardy Regional Section of the Italian Society of Hypertension. The Hyper-Pract Study: A multicentre survey on the accuracy of the echocardiographic assessment of hypertensive left ventricular hypertrophy in clinical practice. Blood Press 2008; 17: 124-128.
31. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, et al., Chamber Quantification Writing Group; American Society of Echocardiography's Guidelines and Standards Committee; European Association of Echocardiography. Recommendations for chamber quantification: A report from the American Society of Echocardiography's Guidelines and Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005; 18: 1440-1463.